EGFR and non-small cell lung carcinoma: The mutations of EGFR in NSCLC are concentrated in exons 18–20, encoding the tyrosine kinase domain, and they affect the ATP binding pocket of the tyrosine kinase domain and lead to ligand-independent activation of EGFR.